Home › Funds › Brevan Howard Capital Management LP › MRNA

Brevan Howard Capital Management LP position in MRNA

MODERNA INC · Health Care

Brevan Howard Capital Management LP reported holding 483,922 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$93.2M, representing 1.60% of its reported portfolio and ranking #6 among its reported holdings. Brevan Howard Capital Management LP has disclosed MRNA holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)483.92K sh
Reported value held$93.19M
Portfolio Weight1.60%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Brevan Howard Capital Management LP's MRNA position evolved

Brevan Howard Capital Management LP first disclosed a stake in MRNA in Q3 2023 at 157,000 shares (US$16.2M). The position peaked in Q3 2026 at 483,922 shares, worth US$93.2M. Across 6 filings, Brevan Howard Capital Management LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 483,922 shares valued at US$93.2M — an increase of 302,817 shares quarter over quarter.. Notable position changes include a 735% increase in Q1 2026 (shares rose 38% over the following quarter), a 102% increase in Q2 2026 (shares rose 175% over the following quarter), a 167% increase in Q3 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 157.00K $16.22M New
Q2 2024 3.15K $373.59K New
Q4 2025 10.73K $316.40K New
Q1 2026 89.59K $4.55M Add
Q2 2026 181.10K $12.68M Add
Q3 2026 483.92K $93.19M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRNA and 13F data

MRNA (MODERNA INC) is a Health Care company. 47 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRNA

All MRNA fund holders →

FAQ

How long has Brevan Howard Capital Management LP held MRNA?

Brevan Howard Capital Management LP has disclosed MRNA holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

What is Brevan Howard Capital Management LP's current position in MRNA?

As of Q3 2026, Brevan Howard Capital Management LP holds 483.92K shares of MRNA (MODERNA INC), valued at $93.19M, representing 1.60% of its reported portfolio and ranking #6.

Has Brevan Howard Capital Management LP been buying or selling MRNA?

In the latest 13F filing (Q3 2026), Brevan Howard Capital Management LP increased its position in MRNA. The position peaked in Q3 2026 at 483.92K shares.

Which other funds hold MRNA?

Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.